Product name as reported
Adrenaclick: adverse event reports filed with FDA
687 reports list it as a suspect or interacting product, 2011–2026.
- 687
- reports as suspect product
- 0% of all reports · about 45 a year
- 50
- reports, 12 months to June 2026
- 44 in the 12 months before
- 78.5%
- marked serious by the reporter
- 57.4% across all reports
- 8.4%
- record death among outcomes, as reported
- 58 reports · not verified by FDA
687 adverse event reports received by FDA list the product name "Adrenaclick" as reporters wrote it as a suspect or interacting product, from February 2011 to June 2026. A further 18 reports list it only as a concomitant medication, and those are not counted in the figures on this page.
In the 12 months to June 2026, 50 reports listed it, up 14% from 44 in the 12 months before. FDA releases FAERS data quarterly, so the newest months are incomplete and grow in later releases. Over its reporting history that is about 45 reports a year and 0% of the 20,646,523 reports in the database. How many people take it is not in the data, so a count is not a rate of occurrence.
The reactions recorded most often are no adverse event (25.2%), drug ineffective (10.3%) and device issue (9.6%). A report can list several reactions, so shares add to more than 100%; 130 different terms appear across these reports. No adverse event is recorded in 25.2% of these reports, against 0.8% of all reports in the database.
78.5% of the reports are marked serious by the reporter; 8.4% record death among the outcomes and 19.7% record hospitalisation, as reported. 42.9% of the reports came from consumers, and the largest patient age group is 18 to 44 (23.9%). FDA states that "a causal relationship cannot be established between product and reactions listed in a report" and that for any given report "there is no certainty that a suspected drug caused the event."
Reports by month, five years
Reports by the month FDA received them. FDA releases FAERS data quarterly, so the newest months are incomplete and grow in later releases.
By year received
2026 covers reports received through June 2026 only.
Reactions recorded in the reports
share of Adrenaclick reports recording the termall reports in the database
- No adverse eventno adverse event was reported25.2%173
- Drug ineffectivethe medicine did not work as expected10.3%71
- Device issuea problem with the device9.6%66
- Needle issuea problem with the needle9.3%64
- Stress cardiomyopathy8.6%59
- Device failurethe device failed7.6%52
- Therapeutic response decreasedthe medicine worked less well6.4%44
- Device malfunctionthe device did not work properly5.1%35
- Cardiac arrestthe heart stopped3.8%26
- Device leakagethe device leaked2.2%15
- Expired product administeredthe product was used past its expiry date2.2%15
- Cardiogenic shockshock from the heart failing to pump2%14
- Accidental overdosean accidental overdose1.9%13
- Device defective1.9%13
- Kounis syndrome1.9%13
- Hypertensionhigh blood pressure1.7%12
- Arteriospasm coronary1.5%10
- Device delivery system issuea problem with the delivery system1.5%10
- Incorrect route of product administrationthe product was given by the wrong route1.5%10
- Tachycardiafast heart rate1.2%8
- Adverse eventan unwanted medical event, type not specified1%7
- Condition aggravatedthe condition being treated got worse1%7
- Device deployment issuethe device did not deploy properly1%7
- Hypotensionlow blood pressure1%7
- Intentional overdosea deliberate overdose1%7
Top 30 of 130 MedDRA preferred terms recorded across these reports, with a plain-language gloss where one is available. One report can record several terms. The hollow bar is the share of all reports in the database; it describes the reports, not the patients. FDA states that adverse event reports "represent a small percentage of total usage numbers of a product", that "common products may have a higher number of adverse events due to the higher total number of people using the product", and that the data "by themselves are not an indicator of the safety profile of the drug or biologic."
Outcomes recorded
Outcome flags as the reporter set them; a report can carry several, and "other serious" is FDA's own category for serious reports outside the named outcomes. Grey bar: all 20,646,523 reports. FDA has not verified any outcome and states that the reports "cannot be used to estimate the incidence of these events."
Patients and reporters
Patient age
Patient sex
Who reported
Age and sex as stated in the report; the reporter's qualification is the primary source recorded by FDA. 76% of reports give the United States as the country of the event or reporter.
Reason for use recorded
| Indication as recorded (MedDRA) | Reports | Share |
|---|---|---|
| Anaphylactic reaction | 198 | 28.8% |
| Hypersensitivity | 55 | 8% |
| Cardiac arrest | 12 | 1.7% |
| Anaphylactic shock | 11 | 1.6% |
| Allergy to arthropod sting | 9 | 1.3% |
| Food allergy | 8 | 1.2% |
The indication field is filled in by the reporter and is often blank; shares are of all 687 reports.
In context
| Measure | Adrenaclick | All reports |
|---|---|---|
| Reports as suspect product | 687 | 20,646,523 |
| Share of that pool | — | 0% |
| Reports, latest 12 months | 50 | 1,332,454 |
| Marked serious | 78.5% | 57.4% |
| Death recorded among outcomes, per 1,000 reports | 84 | 91 |
| Hospitalisation recorded, per 1,000 reports | 197 | 213 |
| Consumer-filed share | 42.9% | 45.8% |
| Top term, share of reports | No adverse event 25.2% | 0.8% |
Shares are of reports, not of patients treated. The number of people taking a product is not in the data, so none of these figures is a rate, and differences between columns reflect who takes a product, who reports and how long it has been sold. FDA states that adverse event reports "represent a small percentage of total usage numbers of a product", that "common products may have a higher number of adverse events due to the higher total number of people using the product", and that the data "by themselves are not an indicator of the safety profile of the drug or biologic."
Questions about Adrenaclick reports
How many adverse event reports has FDA received for Adrenaclick?
687 reports list Adrenaclick as a suspect or interacting product in the openFDA FAERS release of 28 Sep 2026, covering reports received through June 2026. 50 of them arrived in the latest 12 months. Another 18 list it only as a concomitant medication.
What reactions are recorded in Adrenaclick reports?
no adverse event (25.2%), drug ineffective (10.3%), device issue (9.6%), needle issue (9.3%) and stress cardiomyopathy (8.6%). These are MedDRA preferred terms coded from what the reporter described; a report can list several, and a term's presence is not a finding that Adrenaclick was responsible.
How serious are the reports?
78.5% are marked serious by the reporter. Among the outcomes recorded, 8.4% of reports include death and 19.7% include hospitalisation. FDA has not verified these outcomes and states that the reports "cannot be used to estimate the incidence" of the events.
Who files these reports?
consumer or non-health professional (42.9%), other health professional (31%) and physician (12.4%). Most reports reach FDA through the manufacturer, which must forward reports it receives.
Are reports for Adrenaclick rising?
50 reports in the 12 months to June 2026, up 14% from 44 in the 12 months before. FDA releases FAERS data quarterly, so the newest months are incomplete and grow in later releases. Counts also move with how many people take a product, its time on the market and publicity.
Do these reports show that Adrenaclick was responsible for these reactions?
No. FDA states that "a causal relationship cannot be established between product and reactions listed in a report" and that for any given report "there is no certainty that a suspected drug caused the event." The reaction may relate to the condition being treated, to other medicines, or to something else.
Is this a list of the side effects of Adrenaclick?
No. It is a count of what was reported to FDA. The adverse reactions observed in clinical studies are printed on the FDA-approved label, which a pharmacist or clinician can go through with you.
How do I report an adverse event?
Consumers and health professionals can report to FDA through MedWatch (Form FDA 3500 online, or 1-800-FDA-1088), or to the manufacturer, which must pass reports on. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Drug Adverse Event (FAERS) bulk export released 28 Sep 2026, which holds reports FDA received through 30 Jun 2026. Drug names are as reported, resolved to the brand or generic name on the FDA label where openFDA's harmonisation matched them; classes are the pharmacologic class (EPC) from the label and the National Drug Code Directory of 17 Sep 2026. A report counts here when it lists Adrenaclick as a suspect or interacting product; reports listing it only as a concomitant medication (18) are excluded. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.